BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15997677)

  • 1. [Comparison of the urodynamic stop-flow test and degree of obstruction in prediction of postprostatectomy outcome].
    Aganović D; Prcić A; Junuzović D; Kulovac B
    Med Arh; 2005; 59(3):174-6. PubMed ID: 15997677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The urodynamic nomogram in defining the degree of obstruction in patients with benign prostatic enlargement--defining clear obstruction].
    Aganović D
    Med Arh; 2003; 57(2):81-6. PubMed ID: 12822379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of uroflowmetry in diagnosis of infravesical obstruction in the patients with benign prostatic enlargement.
    Aganovic D
    Med Arh; 2004; 58(1 Suppl 2):109-11. PubMed ID: 15137221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Grading of benign prostatic obstruction can predict the outcome of transurethral prostatectomy.
    Javlé P; Jenkins SA; Machin DG; Parsons KF
    J Urol; 1998 Nov; 160(5):1713-7. PubMed ID: 9783938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of doxazosin efficacy in the treatment of the benign prostatic enlargement].
    Aganović D; Aganović K; Prcić A
    Med Arh; 2004; 58(3):153-6. PubMed ID: 15484855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detrusor contraction duration and strength in the patients with benign prostatic enlargement.
    Aganović D; Prcić A
    Bosn J Basic Med Sci; 2004 Feb; 4(1):29-33. PubMed ID: 15628977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age and bladder outlet obstruction are independently associated with detrusor overactivity in patients with benign prostatic hyperplasia.
    Oelke M; Baard J; Wijkstra H; de la Rosette JJ; Jonas U; Höfner K
    Eur Urol; 2008 Aug; 54(2):419-26. PubMed ID: 18325657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of voiding dysfunction in patients awaiting transurethral prostatectomy.
    Javlé P; Jenkins SA; West C; Parsons KF
    J Urol; 1996 Sep; 156(3):1014-8; discussion 1018-9. PubMed ID: 8709299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of photoselective vaporization of the prostate on urodynamics in patients with benign prostatic hyperplasia.
    Seki N; Nomura H; Yamaguchi A; Naito S
    J Urol; 2008 Sep; 180(3):1024-8; discussion 1028-9. PubMed ID: 18639299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of short-term overactive bladder symptom improvement after transurethral resection of prostate in men with benign prostatic obstruction.
    Zhao YR; Liu WZ; Guralnick M; Niu WJ; Wang Y; Sun G; Xu Y
    Int J Urol; 2014 Oct; 21(10):1035-40. PubMed ID: 24825248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional outcome following photoselective vaporisation of the prostate (PVP): urodynamic findings within 12 months follow-up.
    Hamann MF; Naumann CM; Seif C; van der Horst C; Jünemann KP; Braun PM
    Eur Urol; 2008 Oct; 54(4):902-7. PubMed ID: 18502565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of silodosin for relieving benign prostatic obstruction: prospective pressure flow study.
    Matsukawa Y; Gotoh M; Komatsu T; Funahashi Y; Sassa N; Hattori R
    J Urol; 2009 Dec; 182(6):2831-5. PubMed ID: 19837428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Urodynamic study of obstructive uropathy due to benign prostatic hyperplasia].
    Fedel V; Povrzanović I; Fedel I
    Lijec Vjesn; 1992; 114(9-12):259-61. PubMed ID: 1285282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urodynamic effects of dutasteride add-on therapy to alpha-adrenergic antagonist for patients with benign prostatic enlargement: prospective pressure-flow study.
    Wada N; Kita M; Hashizume K; Matsumoto S; Kakizaki H
    Neurourol Urodyn; 2013 Nov; 32(8):1123-7. PubMed ID: 23861329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urodynamic assessment in the laser treatment of benign prostatic enlargement.
    Te Slaa E; de Wildt MJ; Rosier PF; Wijkstra H; Debruyne FM; de la Rosette JJ
    Br J Urol; 1995 Nov; 76(5):604-10. PubMed ID: 8535680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urodynamics after TURP and HoLEP in urodynamically obstructed patients: are there any differences at 1 year of follow-up?
    Rigatti L; Naspro R; Salonia A; Centemero A; Ghezzi M; Guazzoni G; Briganti A; Rigatti P; Montorsi F
    Urology; 2006 Jun; 67(6):1193-8. PubMed ID: 16750253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of prostatic obstruction with a combination of isometric detrusor contraction pressure and maximum urinary flow rate.
    Comiter CV; Sullivan MP; Schacterle RS; Yalla SV
    Urology; 1996 Nov; 48(5):723-9; discussion 729-30. PubMed ID: 8911516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urodynamics in prostatism. I. Prognostic value of uroflowmetry.
    Jensen KM; Jørgensen JB; Mogensen P
    Scand J Urol Nephrol; 1988; 22(2):109-17. PubMed ID: 2462745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Urethral opening pressure: its clinical significance in prostatic obstruction].
    Ameda K; Kobayashi S; Matsuura S; Sasaki Y; Shibata T; Koyanagi T
    Nihon Hinyokika Gakkai Zasshi; 1997 Apr; 88(4):496-502. PubMed ID: 9155117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detrusor instability with equivocal obstruction: A predictor of unfavorable symptomatic outcomes after transurethral prostatectomy.
    Machino R; Kakizaki H; Ameda K; Shibata T; Tanaka H; Matsuura S; Koyanagi T
    Neurourol Urodyn; 2002; 21(5):444-9. PubMed ID: 12232878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.